Quick answers
- What is Invanz?
- Invanz is a brand name of Ertapenem sodium, a prescription medicine. The FDA NDC Directory lists 1 Invanz product in 1 strength and form.
- Who makes Invanz?
- MSD Sub Merck holds the FDA application for Invanz (NDA021337, approved November 21, 2001).
- Is there a generic or store brand of Invanz?
- Yes. The FDA NDC Directory lists 12 other products with the same active ingredients, strength and form as a Invanz product, 11 of them generic. Ask your pharmacist whether one is right for you.
- Has Invanz been recalled?
- No recall linked to Invanz products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Invanz is
Each Invanz product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Ertapenem sodium · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| ertapenem sodium 1 g injection, powder, lyophilized, for solution (intramuscular, intravenous) | Invanz | 12 products, 11 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Ertapenem sodium →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021337 | MSD Sub Merck | November 21, 2001 | 1 |
Companies that list Invanz
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Invanz products.
- Merck Sharp & Dohme LLC1 product
Recalls
No recall linked to Invanz products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.